查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1451854

2024-2032 年單核苷酸多態性基因分型市場報告（按技術、應用和地區）

Single Nucleotide Polymorphism Genotyping Market Report by Technology, Application, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3個工作天內

價格

2023年全球單核苷酸多態性（SNP）基因分型市場規模達98億美元。展望未來， IMARC Group預計到2032年市場規模將達到379億美元，2024-2032年複合年成長率（CAGR）為15.79% 。不斷成長的基因型研究和開發活動、對個人化醫療和新型藥物輸送系統的需求不斷成長，以及對動植物原料遺傳分析的需求不斷成長，是推動市場的一些關鍵因素。

單核苷酸多態性 (SNP) 基因分型是一種透過檢查脫​​氧核糖核酸 (DNA) 序列中的特定位置來識別和分析個體遺傳變異的技術。它涉及確定個體 DNA 中特定 SNP 位點上存在的特定核苷酸。它依賴先進的分子生物學技術，例如聚合酶鍊式反應（PCR）和DNA測序，其中PCR擴增含有SNP的DNA片段，然後通過直接對擴增的DNA進行測序或使用其他方法來確定SNP位點的核苷酸。微陣列或等位基因特異性 PCR 等方法。它有助於了解群體遺傳學、遷移模式和演化歷史。它在確定藥物反應、預測疾病易感性以及根據特定基因譜客製化治療方面發揮著至關重要的作用。研究人員使用 SNP 基因分型來研究複雜疾病的遺傳基礎、識別遺傳風險因子並開發增強的診斷工具。

單核苷酸多態性 (SNP) 基因分型市場趨勢：

目前，由於基因型研究和開發活動的增加以及生物資訊學在開發各種疾病的診斷工具或有效療法中的應用，對SNP基因分型的需求不斷增加，這是支持市場成長的關鍵因素之一。此外，SNP 基因分型在癌症、心血管、阿茲海默症和氣喘等各種人類疾病的病因中的應用日益廣泛，提供了良好的市場前景。除此之外，世界各地對 SNP 基因分型建立遺傳關係、解決親子糾紛和協助刑事調查的需求不斷增加。這與蓬勃發展的醫療產業一起推動了市場的成長。此外，由於個人化醫療和新型藥物輸送系統的管道不斷增加，對藥物基因組學的需求不斷增加，正在加強市場的成長。除此之外，生命科學領域的許多SNP基因分型技術，如農業生物技術、診斷研究、製藥、藥物基因組學以及動物和牲畜育種，正在促進市場的成長。與此一致的是，全球糖尿病、心血管疾病和癌症盛行率的不斷上升正在對市場產生積極影響。此外，對動植物原料遺傳分析的需求不斷成長，也推動了市場的成長。

本報告回答的關鍵問題：

  • 迄今為止，全球單核苷酸多態性 (SNP) 基因分型市場的表現如何，未來幾年將如何表現？
  • 全球單核苷酸多態性 (SNP) 基因分型市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球單核苷酸多態性 (SNP) 基因分型市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的單核苷酸多態性 (SNP) 基因分型市場？
  • 基於技術的市場區隔是什麼？
  • 單核苷酸多態性 (SNP) 基因分型市場中最具吸引力的技術是什麼？
  • 基於應用程式的市場區隔是什麼？
  • 單核苷酸多態性 (SNP) 基因分型市場中最具吸引力的應用是什麼？
  • 全球單核苷酸多態性（SNP）基因分型市場的競爭格局如何？
  • 全球單核苷酸多態性 (SNP) 基因分型市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球單核苷酸多態性 (SNP) 基因分型市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依技術

  • TaqMan SNP 基因分型
    • 市場走向
    • 市場預測
  • Massarray SNP 基因分型
    • 市場走向
    • 市場預測
  • SNP 基因晶片陣列
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：市場區隔：按應用

  • 動物遺傳學
    • 市場走向
    • 市場預測
  • 工廠改進
    • 市場走向
    • 市場預測
  • 診斷研究
    • 市場走向
    • 市場預測
  • 藥物和藥物基因組學
    • 市場走向
    • 市場預測
  • 農業生物技術
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：市場區隔：按地區

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 9 章：促進因素、限制與機會

  • 概述
  • 促進要素
  • 限制
  • 機會

第 10 章：價值鏈分析

第 11 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 12 章：價格分析

第13章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Agilent Technologies Inc.
    • Eurofins Genomics (Eurofins Scientific SE)
    • Illumina Inc.
    • Integrated DNA Technologies, Inc. (Danaher Corporation)
    • LGC Limited
    • PREMIER Biosoft
    • Promega Corporation
    • QIAGEN NV
    • Roche Holding AG
    • Thermo Fisher Scientific Inc.
Product Code: SR112024A8146

The global single nucleotide polymorphism (SNP) genotyping market size reached US$ 9.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 37.9 Billion by 2032, exhibiting a growth rate (CAGR) of 15.79% during 2024-2032. The growing genotype research and development activities, rising demand for personalized medicine and novel drug delivery systems, and increasing demand for genetic analysis in animal and plant feedstock represent some of the key factors driving the market.

Single nucleotide polymorphism (SNP) genotyping is a technique designed to identify and analyze genetic variations among individuals by examining specific locations within their deoxyribonucleic acid (DNA) sequence. It involves determining the specific nucleotide present at a particular SNP site in the DNA of an individual. It relies on advanced molecular biology techniques, such as polymerase chain reaction (PCR) and DNA sequencing, wherein PCR amplifies the DNA segment containing the SNP, and then the nucleotide at the SNP site is determined either by directly sequencing the amplified DNA or using other methods like microarrays or allele-specific PCR. It aids in understanding population genetics, migration patterns, and evolutionary history. It plays a crucial role in determining response to medications, predicting disease susceptibility, and tailoring treatments to specific genetic profiles. SNP genotyping is used by researchers to study the genetic basis of complex diseases, identify genetic risk factors, and develop enhanced diagnostic tools.

Single Nucleotide Polymorphism (SNP) Genotyping Market Trends:

At present, the increasing demand for SNP genotyping on account of the rising genotype research and development activities and bioinformatics in the development of diagnostic tools or effective therapeutics for various diseases represents one of the crucial factors supporting the growth of the market. In addition, the growing utilization of SNP genotyping in the etiology of various human diseases, such as cancer, cardiovascular, Alzheimer's, and asthma, is offering a favorable market outlook. Besides this, there is a rise in the demand for SNP genotyping to establish genetic relationships, resolve paternity disputes, and assist in criminal investigations around the world. This, along with the thriving medical industry, is propelling the growth of the market. Moreover, the increasing demand for pharmacogenomics due to the rising pipeline for personalized medicine and novel drug delivery systems is strengthening the growth of the market. Apart from this, numerous technologies of SNP genotyping in the life science field, such as agricultural biotechnology, diagnostic research, pharmaceuticals, pharmacogenomics, and animal and livestock breeding, are contributing to the growth of the market. In line with this, the growing prevalence of diabetes, cardiovascular diseases, and cancer across the globe is positively influencing the market. Furthermore, the rising demand for genetic analysis in animal and plant feedstock is bolstering the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global single nucleotide polymorphism (SNP) genotyping market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on technology and application.

Technology Insights:

TaqMan SNP Genotyping

Massarray SNP Genotyping

SNP GeneChip Arrays

Others

The report has provided a detailed breakup and analysis of the single nucleotide polymorphism (SNP) genotyping market based on the technology. This includes TaqMan SNP genotyping, massarray SNP genotyping, SNP GeneChip arrays, and others.

Application Insights:

Animal Genetics

Plant Improvement

Diagnostic Research

Pharmaceuticals and Pharmacogenomics

Agricultural Biotechnology

Others

A detailed breakup and analysis of the single nucleotide polymorphism (SNP) genotyping market based on the application has also been provided in the report. This includes animal genetics, plant improvement, diagnostic research, pharmaceuticals and pharmacogenomics, agricultural biotechnology, and others. According to the report, pharmaceuticals and pharmacogenomics accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for single nucleotide polymorphism (SNP) genotyping. Some of the factors driving the North America single nucleotide polymorphism (SNP) genotyping market included favorable government policies towards proper diagnosis, increasing screening and treatment of fatal diseases, availability of enhanced research and development (R&D) facilities, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global single nucleotide polymorphism (SNP) genotyping market. Detailed profiles of all major companies have been provided. Some of the companies covered include Agilent Technologies Inc., Eurofins Genomics (Eurofins Scientific SE), Illumina Inc., Integrated DNA Technologies, Inc. (Danaher Corporation), LGC Limited, PREMIER Biosoft, Promega Corporation, QIAGEN N.V, Roche Holding AG, Thermo Fisher Scientific Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global single nucleotide polymorphism (SNP) genotyping market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global single nucleotide polymorphism (SNP) genotyping market?
  • What is the impact of each driver, restraint, and opportunity on the global single nucleotide polymorphism (SNP) genotyping market?
  • What are the key regional markets?
  • Which countries represent the most attractive single nucleotide polymorphism (SNP) genotyping market?
  • What is the breakup of the market based on the technology?
  • Which is the most attractive technology in the single nucleotide polymorphism (SNP) genotyping market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the single nucleotide polymorphism (SNP) genotyping market?
  • What is the competitive structure of the global single nucleotide polymorphism (SNP) genotyping market?
  • Who are the key players/companies in the global single nucleotide polymorphism (SNP) genotyping market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Single Nucleotide Polymorphism (SNP) Genotyping Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technology

  • 6.1 TaqMan SNP Genotyping
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Massarray SNP Genotyping
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 SNP GeneChip Arrays
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Animal Genetics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Plant Improvement
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Diagnostic Research
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Pharmaceuticals and Pharmacogenomics
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Agricultural Biotechnology
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

  • 9.1 Overview
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Agilent Technologies Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Eurofins Genomics (Eurofins Scientific SE)
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Illumina Inc.
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Integrated DNA Technologies, Inc. (Danaher Corporation)
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 LGC Limited
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 PREMIER Biosoft
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 Promega Corporation
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 QIAGEN N.V
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Roche Holding AG
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
    • 13.3.10 Thermo Fisher Scientific Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Major Drivers and Challenges
  • Figure 2: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Breakup by Technology (in %), 2023
  • Figure 5: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Single Nucleotide Polymorphism (SNP) Genotyping (TaqMan SNP Genotyping) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 8: Global: Single Nucleotide Polymorphism (SNP) Genotyping (TaqMan SNP Genotyping) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 9: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Massarray SNP Genotyping) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Massarray SNP Genotyping) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Single Nucleotide Polymorphism (SNP) Genotyping (SNP GeneChip Arrays) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Single Nucleotide Polymorphism (SNP) Genotyping (SNP GeneChip Arrays) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Animal Genetics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Animal Genetics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Plant Improvement) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Plant Improvement) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Diagnostic Research) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Diagnostic Research) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Pharmaceuticals and Pharmacogenomics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Pharmaceuticals and Pharmacogenomics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Agricultural Biotechnology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Agricultural Biotechnology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: North America: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: North America: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: United States: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: United States: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Canada: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Canada: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Asia-Pacific: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Asia-Pacific: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: China: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: China: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Japan: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Japan: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: India: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: India: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: South Korea: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: South Korea: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Australia: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Australia: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Indonesia: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Indonesia: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Others: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Others: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Europe: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Europe: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Germany: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Germany: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: France: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: France: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: United Kingdom: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: United Kingdom: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Italy: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Italy: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Spain: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Spain: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Russia: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Russia: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Others: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Others: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Latin America: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Latin America: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Brazil: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Brazil: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Mexico: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Mexico: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Others: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Others: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Middle East and Africa: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Middle East and Africa: Single Nucleotide Polymorphism (SNP) Genotyping Market: Breakup by Country (in %), 2023
  • Figure 75: Middle East and Africa: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Global: Single Nucleotide Polymorphism (SNP) Genotyping Industry: Drivers, Restraints, and Opportunities
  • Figure 77: Global: Single Nucleotide Polymorphism (SNP) Genotyping Industry: Value Chain Analysis
  • Figure 78: Global: Single Nucleotide Polymorphism (SNP) Genotyping Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 3: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Competitive Structure
  • Table 6: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Key Players